Document:

<PAGE>

                                                                 EXHIBIT 10.39

                    FIFTH AMENDMENT TO CREDIT AGREEMENT AND CONSENT

      THIS FIFTH AMENDMENT TO CREDIT AGREEMENT AND CONSENT, dated as of the 30th
day of April, 2004 (this "Amendment"), is made by and between PROVINCE
HEALTHCARE COMPANY, a Delaware corporation (the "Borrower"), the Lenders (as
hereinafter defined) that have executed this Amendment (the "Required Lenders"),
and WACHOVIA BANK, NATIONAL ASSOCIATION, as agent for the Lenders (in such
capacity, the "Agent").

                              BACKGROUND STATEMENT

      A. The Borrower, certain banks and other financial institutions (the
"Lenders"), the Agent, Bank of America, N.A., as Syndication Agent, and UBS
Warburg LLC and Merrill Lynch Capital Corporation, as Documentation Agents, are
parties to a Third Amended and Restated Credit Agreement, dated as of November
13, 2001, as amended by that certain Amendment No. 1 to Certain Operative
Agreements, dated as of March 29, 2002, by that certain Second Amendment to
Credit Agreement and Consent, dated as of March 28, 2003, by that certain Third
Amendment to Credit Agreement and Consent, dated as of May 27, 2003 and by that
certain Fourth Amendment to Credit Agreement, dated as of June 30, 2003 (as
amended, the "Credit Agreement"), providing for the availability of a revolving
credit facility to the Borrower upon the terms and conditions set forth therein.
Capitalized terms used herein without definition shall have the meanings given
to them in the Credit Agreement.

      B. The Borrower has requested that the Credit Agreement be amended (a) to
exclude the net termination obligations of the Borrower under Swap Agreements
from the definition of "Debt" for certain purposes under the Credit Agreement,
and (b) to increase the required ratio of Consolidated Debt to Consolidated
EBITDA as described herein. Such amendments require the consent of the Required
Lenders under Section 10.8 of the Credit Agreement.

      C. The Borrower has also informed the Agent and the Lenders that it
proposes, through its wholly owned subsidiary, PHC-Las Cruces, Inc., a New
Mexico corporation ("PHC - Las Cruces"), to acquire by lease a hospital located
at 2450 South Telshor Boulevard in Las Cruces, New Mexico and related assets
(the "Las Cruces Hospital") for an aggregate Acquisition Amount not to exceed
$165,000,000 (the "Las Cruces Acquisition"). The Las Cruces Acquisition requires
the consent of the Required Lenders under Sections 5.12 and 6.7 of the Credit
Agreement.

      D. The Borrower has also notified the Agent that it will not consummate
the acquisition of a single licensed hospital located in Paris, Texas that was
consented to by the Required Lenders pursuant to that certain Credit Agreement
Consent, dated as of December 5, 2003 (the "Paris, Texas Acquisition Consent"),
between the Borrower, certain Lenders and the Agent, and that the Borrower has
no obligations to Christus St. Joseph's Health System with respect thereto.

      E. The Borrower has also informed the Agent and the Lenders that it seeks
to exclude for certain purposes under the Credit Agreement non-cash asset
impairment charges and

<PAGE>

non-cash losses from sale not exceeding $15,000,000 in the aggregate (the
"Glades Non-Cash Loss") resulting from the proposed sale of Glades General
Hospital to the Health Care District of Palm Beach County scheduled to close on
or about April 30, 2004. The exclusion of the Glades Non-Cash Loss requires the
consent of the Required Lenders under Section 10.8 of the Credit Agreement.

      F. The Borrower has also informed the Agent and the Lenders that it seeks
to extend the deadline for the Havasu Regional Medical Center transactions
approved by the Required Lenders on the terms and subject to the conditions of
the Consent, dated as of October 28, 2003 (the "Havasu Consent"), between the
Borrower, certain Lenders and the Agent, from March 31, 2004 to June 30, 2004.
Such extension requires the consent of the Required Lenders under Section 10.8
of the Credit Agreement.

      G. The Borrower has also informed the Lenders that it seeks to cause
PHC-Eunice, Inc., a Louisiana corporation ("PHC-Eunice"), to contribute
substantially all of the assets of Eunice Community Medical Center (the "Eunice
Hospital") to Eunice Community Medical Center, LLC, a Delaware limited liability
company ("Eunice LLC"), in exchange for at least 70% of the Capital Stock of
Eunice LLC, which will be owned by PHC-Eunice and/or another wholly owned
Subsidiary of the Borrower (the "Contribution Transaction"). The Credit
Agreement does not currently permit the Contribution Transaction, and,
therefore, the consent of the Required Lenders is required under Section 10.8 of
the Credit Agreement.

      H. The Borrower has also informed the Lenders that it seeks to use up to
$40,000,000 to repurchase a portion of the 4-1/4% Subordinated Notes and/or the
4-1/2% Subordinated Notes from the holders thereof. Such repurchase requires the
consent of the Required Lenders under Section 10.8 of the Credit Agreement.

      I. The Required Lenders have agreed to the amendments and consents
described above on the terms and subject to the conditions set forth herein.

                             STATEMENT OF AGREEMENT

      The parties hereto agree as follows:

                                    ARTICLE I

                                   AMENDMENTS

      1.1 Debt Definition. Section 1.1 of the Credit Agreement is hereby amended
by inserting the following sentence at the end of the definition of "Debt":

      "Notwithstanding the foregoing, solely for the purposes of (i) calculating
the financial covenants set forth in Section 6.9 (Consolidated Debt to
Consolidated EBITDA) and 6.10 (Consolidated Senior Debt to Consolidated EBITDA),
(ii) the definition of "Applicable Margin," and (iii) calculating the commitment
fee payable under Section 2.7(b) of the Credit Agreement, "Debt" shall exclude
the net termination obligations of the Borrower and its Subsidiaries under any
Swap Agreement or other interest rate protection or hedging arrangement."

                                       2
<PAGE>

      1.2 Consolidated Debt to Consolidated EBITDA. Article VI of the Credit
Agreement is hereby amended by deleting Section 6.9 thereof in its entirety and
inserting in lieu thereof the following:

            6.9 Consolidated Debt to Consolidated EBITDA. Permit the ratio of
      Consolidated Debt to Consolidated EBITDA to be greater than 4.25 to 1.0 as
      of the end of any fiscal quarter, beginning with the fiscal quarter ending
      June 30, 2004 to and including the fiscal quarter ending December 31,
      2004; to be greater than 4.00 to 1.0 as of the end of the fiscal quarter
      ending March 31, 2005; and to be greater than 3.75 to 1.0 as of the end of
      any fiscal quarter thereafter.

                                   ARTICLE II

                                    CONSENTS

      2.1 Acquisition of Las Cruces Hospital. Subject to the terms and
conditions of this Amendment, the Required Lenders hereby consent to the
consummation of the Las Cruces Acquisition on or prior to July 1, 2004;
provided, that (i) immediately prior to and immediately following the Las Cruces
Acquisition, no Default or Event of Default shall exist and be continuing; (ii)
the Acquisition Amount for the Las Cruces Acquisition shall not exceed
$165,000,000, with no more than $135,000,000 of such Acquisition Amount being
funded by Borrowings under the Credit Agreement; (iii) (w) the Agent shall have
received, at the times required by Sections 5.11 and 5.12 of the Credit
Agreement, the documents required pursuant to Sections 5.11 and 5.12 of the
Credit Agreement with respect to the Las Cruces Acquisition, which documents
shall be in form and substance reasonably satisfactory to the Agent, and the
Agent shall have received such other documents, certificates, opinions and
instruments with respect to the Las Cruces Acquisition as the Agent shall
reasonably request and in form and substance reasonably satisfactory to the
Agent, (x) the projected EBITDA contribution levels with respect to the Las
Cruces Acquisition submitted pursuant to Section 5.12(c)(iii) of the Credit
Agreement shall exceed $17,000,000 per year, (y) the Agent shall have approved
(which approval shall not be withheld unreasonably) the draft or drafts of the
acquisition or other purchase or lease agreement or agreements with respect to
the Las Cruces Acquisition delivered pursuant to Section 5.12(c)(i) of the
Credit Agreement and (z) the Las Cruces Acquisition is consummated pursuant to
the terms of such draft agreements (with such amendments, waivers, replacements
and/or substitutions as are approved by the Agent, which approval shall not be
withheld unreasonably); (iii) since the date of the most recent historical
financial statements delivered to the Agent with respect to the Las Cruces
Acquisition pursuant to Section 5.12(c)(ii) of the Credit Agreement, no material
adverse change shall have occurred in the business, properties, prospects,
operations or condition (financial or otherwise) of Las Cruces Hospital, and no
event, condition or state of facts that could reasonably be expected to have
such a material adverse effect shall have occurred; (iv) the Borrower shall be
in pro forma compliance after giving effect to the Las Cruces Acquisition with
the financial covenants set forth in Sections 6.9 through 6.13 of the Credit
Agreement for the most recent calculation period for which financials statements
are available immediately prior to the date of the Las Cruces Acquisition; and
(v) a Compliance Certificate shall have been delivered to the Agent at the
closing of the Las Cruces Acquisition showing pro forma covenant compliance with
each of the financial covenants set forth in Sections 6.9 through 6.13 of the
Credit Agreement after giving

                                        3
<PAGE>

effect to the Las Cruces Acquisition; and (vi) at the closing of the Las Cruces
Acquisition, the personal property of PHC-Las Cruces, and within 60 days after
the closing of the Las Cruces Acquisition, the leasehold interest in the Realty
of Las Cruces Hospital, shall be pledged to the Agent for the benefit of the
Lenders pursuant to documentation satisfactory to the Agent (including, without
limitation, an accession to the Security Agreement executed by PHC-Las Cruces,
documentation of the type described in Sections 3.1.l(e), (f) and (g) of the
Credit Agreement, and such other Security Documents reasonably required for the
pledge of such personal property and Realty of PHC-Las Cruces).

      Notwithstanding the foregoing, any Capital Expenditures with respect to
Las Cruces Hospital, any assumption of Debt or Liens in connection with the
acquisition of Las Cruces Hospital, and any other post-closing transactions
involving Las Cruces Hospital or the seller thereof shall be subject to the
covenants and provisions of the Credit Agreement (including any required
approvals) at the time of such expenditure, assumption or transaction. This
Consent is limited strictly to the consummation of the Las Cruces Acquisition as
described in the preceding paragraph, and shall not be deemed to be a consent
to, or modification of, any other term or provision of the Credit Agreement or
any other Loan Document or other instrument referred to therein or herein, or of
any transaction or further or future action on the part of the Borrower or any
other Person which would require the consent of the Agent or any of the Lenders
under the Credit Agreement or any such Loan Document or instrument.

      The Borrower and the Required Lenders acknowledge and agree that, with
respect to the Las Cruces Acquisition, a $62,500,000 Acquisition Amount shall be
deemed to exist (and shall apply to reduce the $125,000,000 aggregate
acquisition basket set forth in the definition of "Permitted Acquisition") from
the date hereof until the earlier of (A) notification by the Borrower to the
Agent that the Borrower has determined not to consummate the Las Cruces
Acquisition and has no obligations to the seller with respect thereto (at which
point the consent set forth in this Section 2.1 shall be deemed revoked), or (B)
the closing of the Las Cruces Acquisition, at which point, notwithstanding the
actual Acquisition Amount for the Las Cruces Acquisition, a $62,500,000
Acquisition Amount shall be deemed to apply for all purposes of the Credit
Agreement.

      2.2 Glades Non-Cash Loss. Subject to the terms and conditions of this
Amendment, the Required Lenders hereby consent to the exclusion of the Glades
Non-Cash Loss from the calculation of Consolidated EBITDA (to the extent such
Glades Non-Cash Loss was taken into account for any period in the calculation of
Consolidated Net Income) for purposes of (i) the calculation of the covenants
set forth in Section 6.9 (Consolidated Debt to Consolidated EBITDA), Section
6.10 (Consolidated Senior Debt to Consolidated EBITDA) and Section 6.13 (Fixed
Charge Coverage), (ii) the definition of "Applicable Margin," and (iii) the
calculation of the commitment fee payable under Section 2.7(b) of the Credit
Agreement.

      2.3 Havasu Syndication Transactions. The Required Lenders hereby consent
to extending the deadline for consummating the transactions contemplated by
Section 1.2 of the Havasu Consent from March 31, 2004 to June 30, 2004;
provided, that such transactions are otherwise consummated on the terms and
subject to the conditions set forth in the Havasu Consent.

                                        4
<PAGE>

      2.4 Eunice Community Medical Center. Subject to the terms and conditions
of this Amendment, the Required Lenders hereby consent to (i) the consummation
of the Contribution Transaction on or before September 30, 2004; (ii) the sale
of up to thirty percent (30%) of the Capital Stock of Eunice LLC for Fair Market
Value to licensed physicians on the medical staff of the Eunice Hospital;
provided, that the remaining Capital Stock in Eunice LLC beneficially owned by
PHC-Eunice, the Borrower or any of its Subsidiaries shall be pledged to the
Agent for the benefit of the Lenders pursuant to the Pledge Agreement; (iii) the
classification of Eunice LLC as a Permitted Joint Venture under the Credit
Agreement; provided, that Eunice LLC shall only be classified as a Permitted
Joint Venture so long as it continues to meet all of the requirements of the
definition of Permitted Joint Venture (except that Eunice LLC shall only be
required to have at least 70% of its Capital Stock owned directly by the
Borrower and/or its wholly owned Subsidiaries, instead of at least 85% of such
Capital Stock as required by the definition), subject to the terms of a limited
liability company operating agreement for Eunice LLC in form and substance
reasonably satisfactory to the Agent, and any violation of the foregoing proviso
shall constitute an Event of Default under the Credit Agreement; and (iv) the
exclusion of the Contribution Transaction from the $20,000,000 baskets provided
in Sections 6.2(v), 6.5(iii) and 6.7(m) of the Credit Agreement; provided, that
each consent of the Required Lenders set forth in this Section 2.4 is
conditioned upon (w) the documentation for the transactions described in this
Section 2.4 being in form and substance satisfactory to the Agent (with evidence
of such satisfaction to be provided by the Agent, if so satisfied, to the
Borrower in writing upon the Borrower's request), (x) both immediately before
and immediately after the Contribution Transaction, there being no Default or
Event of Default that has occurred and is continuing, (y) at the times required
by such Sections 5.11 and 5.12 of the Credit Agreement, the Agent shall have
received the documents required pursuant to Sections 5.11 and 5.12 of the Credit
Agreement with respect to the Contribution Transaction and the Agent shall have
received such other documents, certificates, opinions and instruments with
respect to the Contribution Transaction as the Agent shall reasonably request,
and all such documents shall be in form and substance reasonably satisfactory to
the Agent, and (z) the delivery to the Agent at the closing of the Contribution
Transaction of a certificate, signed by the chief executive officer or chief
financial officer of the Borrower, in form and substance satisfactory to the
Agent, certifying that, after giving effect to the Contribution Transaction and
the reduction of EBITDA related to the sale of Capital Stock in Eunice LLC to
physicians on the medical staff of Eunice Hospital, the Borrower is in pro forma
compliance with the financial covenants set forth in Sections 6.9 though 6.13 of
the Credit Agreement for the most recently ended four fiscal quarters
immediately prior to the consummation of the Contribution Transaction, together
with a calculation supporting such pro forma compliance with the financial
covenant set forth in Section 6.11 of the Credit Agreement.

      2.5 Paris, Texas Acquisition Consent Revocation. The Borrower and the
Required Lenders acknowledge and agree that the Paris, Texas Acquisition Consent
is hereby revoked.

      2.6 Repurchase of 4-1/4% and/or 4-1/2% Subordinated Notes. Subject to the
terms and conditions of this Amendment, the Required Lenders hereby consent to
the use by the Borrower of up to $40,000,000 to repurchase a portion of the
4-1/4% Subordinated Notes and/or the 4-1/2% Subordinated Notes from the holders
thereof; provided, that (i) all such repurchases are made on or before December
31, 2004, (ii) (A) all amounts paid in connection with any repurchase of a
portion of the 4-1/4% Subordinated Notes (including principal, premiums and

                                        5
<PAGE>

customary brokerage fees and transaction expenses) do not exceed, in the
aggregate, 102.4286% of the principal amount of such portion of the 4-1/4%
Subordinated Notes so repurchased plus accrued interest thereon to the date of
repurchase, and/or (B) all amounts paid in connection with any repurchase of a
portion of the 4-1/2% Subordinated Notes (including principal, premiums and
customary brokerage fees and transaction expenses) do not exceed, in the
aggregate, 101.80% of the principal amount of such portion of the 4-1/2%
Subordinated Notes so repurchased plus accrued interest thereon to the date of
repurchase, and (iii) both immediately before and immediately after giving
effect to each such repurchase, no Default or Event of Default shall have
occurred and be continuing. The Borrower and the Required Lenders acknowledge
and agree that the consent contained in this Section 2.6 replaces in its
entirety the consent in Section 1.1 of the Havasu Consent and that Section 1.1
of the Havasu Consent shall have no further force or effect after the date
hereof.

                                   ARTICLE III

                         REPRESENTATIONS AND WARRANTIES

      The Borrower hereby represents and warrants as follows:

      3.1 Representations and Warranties. After giving effect to this Amendment,
each of the representations and warranties of the Borrower contained in the
Credit Agreement and in the other Loan Documents is true and correct on and as
of the date hereof with the same effect as if made on and as of the date hereof
(except to the extent any such representation or warranty is expressly stated to
have been made as of a specific date, in which case such representation or
warranty is true and correct as of such date).

      3.2 No Default. After giving effect to this Amendment, no Default or Event
of Default has occurred and is continuing.

      3.3 Enforceability. This Amendment has been duly executed and delivered by
the Borrower and constitutes the Borrower's legal, valid and binding obligation,
enforceable in accordance with its terms, except as such enforceability may be
limited (x) by general principles of equity and conflicts of laws or (y) by
bankruptcy, reorganization, insolvency, moratorium or other laws of general
application relating to or affecting the enforcement, of creditors' rights.

      3.4 No Conflicts. No consent, approval, authorization or order of, or
filing, registration or qualification with, any court or governmental authority
or third party is required in connection with the execution, delivery or
performance by the Borrower of this Amendment.

      3.5 Obligations. The execution and delivery of this Amendment does not
diminish or reduce the Borrower's obligations under the Loan Documents, except
as modified by this Amendment.

      3.6 No Claims. The Borrower has no claims, counterclaims, offsets or
defenses to the Loan Documents and the performance of its obligations
thereunder, or if the Borrower has any such claims, counterclaims, offsets, or
defenses to the Loan Documents or any transaction related to the Loan Documents,
the same are hereby waived, relinquished and released in consideration of the
Required Lenders' execution and delivery of this Amendment.

                                        6
<PAGE>

                                   ARTICLE IV

                           CONDITIONS TO EFFECTIVENESS

      The effectiveness of the amendments to the Credit Agreement and of the
consents set forth in this Amendment is subject to the satisfaction of the
following conditions:

      4.1 Executed Amendment. This Amendment shall have been duly executed and
delivered by the Borrower, the Agent and the Required Lenders and shall be in
full force and effect.

      4.2 Representations and Warranties; Officer's Certificate. The following
shall be true and the Agent shall have received a certificate, signed by the
chief executive officer or chief financial officer of the Borrower, in form and
substance satisfactory to the Agent, certifying that (i) each of the
representations and warranties of the Borrower contained in this Amendment, the
Credit Agreement and the other Loan Documents is true and correct as of the date
of such certificate after giving effect to this Amendment (except to the extent
any such representation or warranty is expressly stated to have been made as of
a specific date, in which case such representation or warranty is true and
correct as of such date), (ii) no Default or Event of Default has occurred and
is continuing after giving effect to this Amendment, and (iii) each of the
conditions set forth in this ARTICLE IV has been satisfied.

      4.3 No Material Adverse Change. No material adverse change shall have
occurred in the business, properties, prospects, operations or condition
(financial or otherwise) of the Borrower and its Subsidiaries, taken as a whole,
since December 31, 2003, and no event, condition or state of facts that could
reasonably be expected to have such a material adverse effect shall have
occurred since December 31, 2003.

      4.4 Confirmation. The Agent shall have received a Confirmation of Credit
Documents by each Guarantor of the Obligations, in form and substance
satisfactory to the Agent.

                                    ARTICLE V

                                  MISCELLANEOUS

      5.1 Post-Closing Matters. On or before the date that is 60 days after the
date on which the Las Cruces Acquisition is consummated (or such later date as
the Agent may reasonably agree to if the Borrower and its Subsidiaries are
diligently pursuing such items in good faith), the following matters shall have
been completed:

      (a) A Mortgage for the Realty located at Las Cruces Hospital shall have
been duly authorized, executed and delivered by PHC-Las Cruces, shall have been
recorded, registered and filed in a manner reasonably acceptable to the Agent,
shall be in full force and effect and no Default shall exist thereunder, and the
Agent shall have received a fully executed copy thereof.

      (b) A fixture filing with respect to the fixtures at Las Cruces Hospital,
in form and substance reasonably satisfactory to the Agent, shall have been
filed.

                                        7
<PAGE>

      (c) The Agent, for the benefit of the Lenders, shall have received a
policy of title insurance or a title insurance binder in form and substance
reasonably satisfactory to the Agent, from a title insurance company duly
licensed to do business in New Mexico, selected by the Borrower and reasonably
acceptable to the Agent, in an amount reasonably satisfactory to the Agent but
not to exceed the fair market value of the Realty, with respect to each tract of
Realty being encumbered by the lien of the Mortgage for Las Cruces Hospital, all
premiums thereon shall have been paid, and such policy shall insure that the
Mortgage for Las Cruces Hospital constitutes a valid, enforceable, first
priority lien on the Realty subject thereto, free and clear from all title
defects and encumbrances whatsoever except for and subject to Permitted Liens,
and only with exceptions for rights of physicians or other healthcare providers
as tenants under written leases of office space in the ordinary course of
business, but specifically excluding ground leases with terms of ten years or
more, and such other exceptions as are reasonably acceptable to the Agent, and
shall include future advance and revolving credit endorsements, a variable rate
endorsement and such other endorsements as the Agent may reasonably request, to
the extent available in New Mexico. Such title insurance policy (or binder, as
the case may be) with respect to the Realty for Las Cruces Hospital may not
contain general survey exceptions except with the Agent's prior written consent.

      (d) The Agent shall have received a metes-and-bounds survey of each tract
or parcel of the Realty of Las Cruces Hospital being encumbered by the lien of
the Mortgage with respect thereto, in form and substance reasonably satisfactory
to the Agent.

      (e) A favorable opinion of Modrall Sperling Roehl Harris & Sisk, P.A., New
Mexico counsel to the Borrower and the Guarantors, with respect to the Security
Documents to be executed by PHC-Las Cruces in connection with this Amendment,
addressed to the Agent, for the benefit of the Lenders, the Issuing Lender and
each Lender, and in form and substance satisfactory to the Agent, shall have
been delivered to the Agent.

      5.2 Effect of Amendment. From and after the effective date of the
amendments to the Credit Agreement set forth herein, all references to the
Credit Agreement set forth in any other Loan Document or other agreement or
instrument shall, unless otherwise specifically provided, be references to the
Credit Agreement as amended by this Amendment and as may be further amended,
modified, restated or supplemented from time to time. This Amendment is limited
as specified and shall not constitute or be deemed to constitute an amendment,
modification, consent or waiver of any provision of the Credit Agreement or of
any other Loan Document except as expressly set forth herein. Except as
expressly amended hereby, the Credit Agreement shall remain in full force and
effect in accordance with its terms.

      5.3 Governing Law. This Amendment shall be governed by and construed and
enforced in accordance with the laws of the State of North Carolina (without
regard to the conflicts of law provisions thereof).

      5.4 Expenses. The Borrower agrees to pay upon demand all reasonable
out-of-pocket costs and expenses of the Agent (including, without limitation,
the reasonable fees and expenses of counsel to the Agent) in connection with the
preparation, negotiation, execution and delivery of this Amendment.

                                        8
<PAGE>

      5.5 Severability. To the extent any provision of this Amendment is
prohibited by or invalid under the applicable law of any jurisdiction, such
provision shall be ineffective only to the extent of such prohibition or
invalidity and only in any such jurisdiction, without prohibiting or
invalidating such provision in any other jurisdiction or the remaining
provisions of this Amendment in any jurisdiction.

      5.6 Successors and Assigns. This Amendment shall be binding upon, inure to
the benefit of and be enforceable by the respective successors and assigns of
the parties hereto.

      5.7 Construction. The headings of the various sections and subsections of
this Amendment have been inserted for convenience only and shall not in any way
affect the meaning or construction of any of the provisions hereof.

      5.8 Counterparts; Effectiveness. This Amendment may be executed in any
number of counterparts and by different parties hereto on separate counterparts,
each of which when so executed and delivered shall be an original, but all of
which shall together constitute one and the same instrument. This Amendment
shall become effective upon the execution and delivery of a counterpart hereof
by the Borrower, the Agent and the Lenders and the satisfaction of the
conditions set forth in ARTICLE IV hereof.

                                        9
<PAGE>

      IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be
executed by their duly authorized officers as of the date first above written.

                              PROVINCE HEALTHCARE COMPANY

                              By: /s/ Christopher T. Hannon
                                  -------------------------------------------
                                  Name: Christopher T. Hannon
                                  Title: Senior Vice President/Chief Financial
                                         Officer

                              WACHOVIA BANK, NATIONAL
                              ASSOCIATION, as Agent and as Lender

                              By: ______________________________________
                                  Name: Scott Santa Cruz
                                  Title: Director

                                       S-1
<PAGE>

      IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be
executed by their duly authorized officers as of the date first above written.

                              PROVINCE HEALTHCARE COMPANY

                              By: ____________________________________________
                                  Name: Christopher T. Hannon
                                  Title: Senior Vice President/Chief Financial
                                          Officer

                              WACHOVIA BANK, NATIONAL
                              ASSOCIATION, as Agent and as Lender

                              By: /s/ Scott Santa Cruz
                                  ---------------------------------------
                                  Name: Scott Santa Cruz
                                  Title: Director

                                       S-1
<PAGE>

                              BANK OF AMERICA, N.A., AS A LENDER

                              By: /s/ [ILLEGIBLE]
                                  ------------------------------
                                  Name: [ILLEGIBLE]
                                  Title: AVP

                                       S-2
<PAGE>

                              MERRILL LYNCH CAPITAL
                              CORPORATION, AS A LENDER

                              By: /s/ [ILLEGIBLE]
                                  --------------------------------
                                  Name: [ILLEGIBLE]
                                  Title: VICE PRESIDENT

                                       S-3
<PAGE>

                              NATIONAL CITY BANK OF KENTUCKY, AS
                              A LENDER

                              By: /s/ Deroy  Scott
                                  ------------------------------
                                  Name: Deroy  Scott
                                  Title: Senior Vice President

                                       S-4
<PAGE>

                              SUNTRUST BANK, AS A LENDER

                              By: /s/ W. Brooks Hubbard
                                  ---------------------------------
                                  Name: W. Brooks Hubbard
                                  Title: Director

                                       S-7
<PAGE>

                              LASALLE BANK NATIONAL ASSOCIATION,
                              AS A LENDER

                              By: /s/ [ILLEGIBLE]
                                  ---------------------------
                                  Name: [ILLEGIBLE]
                                  Title: First Vice President

                                      S-10
<PAGE>

                              CREDIT LYONNAIS NEW YORK BRANCH,
                              AS A LENDER

                              By: /s/ Charles Heidsieck
                                  ----------------------------------
                                  Name: Charles Heidsieck
                                  Title: Senior Vice PresidentEX-10.1

 

Exhibit 10.1

PORTIONS OF THIS EXHIBIT
HAVE BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT.
SUCH PORTIONS ARE DESIGNATED [REDACTED].

CHIP SUPPLY AGREEMENT

     This CHIP SUPPLY AGREEMENT, effective the  1st  day of
November, 2004, by and between NAN YA PLASTICS CORP., AMERICA, a Delaware corporation (“Seller”),
and UNIFI Manufacturing, Inc., a North Carolina corporation (“Buyer”), with executive offices in
Greensboro, North Carolina.

W I T N E S S E T H:

     WHEREAS, the Buyer owns and operates a partially oriented yarn (“POY”) spinning plant in
Yadkinville, North Carolina (“Yadkinville”), and desires to purchase from Seller fiber grade
polyester semi-dull and bright luster chip (also known as polyethylene terephthalate chip)
(“Chip”) and Seller produces Chip at its plant in Lake City, South Carolina (“Lake City”), and has
heretofore sold and agrees to continue to sell Chip to Buyer; and

     WHEREAS, Buyer and Seller entered into a chip supply Agreement under date of June 19, 2003
which this Agreement updates and supercedes;

     NOW, THEREFORE, the parties hereto, for and in consideration of the sum of ten and no/100
dollars ($10.00) and in consideration of these presents and other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, agree as follows:

SECTION 1. ORIGINAL TERM - The original term of this Agreement shall be for a period of
three (3) years, commencing on the first day of November, 2004, and terminating on the
31st day of October, 2007, unless extended or sooner terminated, as hereinafter provided. If the
Buyer wishes to terminate this Agreement sooner then three years, Buyer may terminate this
Agreement at any time during the term of the Agreement by delivering Seller a written termination
notice six (6) months in advance of the termination date.

SECTION 2. PURCHASE AND SALE OF CHIP -

     (a) The Chip must be produced by Seller and delivered to Buyer in accordance with the
specifications as presented on the Chip Specification Sheets, Exhibit “A”, attached hereto
(“Specification Sheets”) for each luster supplied or in accordance with other specifications
agreed upon in advance by both Buyer and Seller. Seller shall provide Buyer with a continuous
supply of Chip which is in strict compliance with, and within ranges specified for physical and
chemical properties presented in the Specification Sheets. Unless previously agreed upon by the
parties hereto, the continuous supply of each luster of Chip shall be delivered from specific
continuous polymerization units located at Seller’s Lake City plant.

     (b) Effective November 1, 2004, Seller shall manufacture and deliver to Buyer, and
Buyer shall purchase and take from Seller, all Buyer’s requirement of Chip during the term of

 

 

this Agreement needed for its POY spinning plant operations in Yadkinville, North Carolina,
except for such amount of Chip that Buyer shall manufacture or have manufactured for it from fiber
waste and other specialty items such as cationic Chip, made to Buyer’s specifications. This
Agreement obligates Buyer to purchase all its requirement of Chip from Seller for its Yadkinville
spinning plant, but does not obligate Buyer to purchase a minimum amount of Chip from Seller.

     The Chip, as provided in section 2(a), will be delivered in accordance with the production
plan heretofore established between the Buyer and Seller and presently in place, or as otherwise
agreed upon by the parties hereto. Further production and delivery will be conducted as provided
in Section 2(e) herein.

     (c) Upon request by Buyer, Seller shall deliver to Buyer information regarding the production
and process for the Chip being manufactured by Seller for shipment to Buyer, which may be required
for vendor or material “certification of compliance” as required by ISO 9000 or other inbound
material quality monitoring process being used by Buyer or its customers.

     (d) During the term of this Agreement, or any extension thereof, Seller shall make the Chip
available for loading and transport to Buyer’s plant continuously between Mondays at 7:00 AM until
Saturdays at 5:00 PM, or at other times as agreed upon by the parties hereto.

     (e) Buyer shall furnish to Seller a copy of its projected daily needs of the next month Chip
by luster on a monthly basis by the 22nd of the current month for the next succeeding
month. Such projections are for planning purposes only and shall not constitute a binding
commitment of Buyer. Actual orders shall be delivered to the Seller by the Buyer on a monthly
basis.

     (f) Seller shall maintain at its Lake City plant a minimum Chip inventory of five (5) days of
each luster, at no cost to Buyer, to insure that it will have sufficient Chip to meet Buyer’s
orders. Inventory shall be maintained on a rotating basis, first in first out, and no Chip shall
be delivered to Buyer from inventory that does not meet the conditions provided for in Section
2(a) without the Buyer’s written consent.

SECTION 3. PRICING TERMS –

     (a) Base Bulk Purchase Price - The base bulk purchase price (“base price”) for
Semi-Dull Chip, effective as of November 1, 2004, shall be [Redacted] above Seller’s FOB
raw material cost for Pure Terephthalic Acid (“PTA”) and Mono-Ethylene Glycol (“MEG”).

     The base price for Full Bright Chip, effective as of November 1, 2004, shall be
[Redacted] above the base price for semi-dull Chip as provided above.

     (i) The
cost of PTA – In determining said base price as of November 1, 2004, the cost
of PTA for the month beginning November 1, 2004, and for each month thereafter during the term

2

 

of this Agreement, or any extension thereof, shall be the published November, 2004 market
price as quoted in [Redacted], hereinafter referred to as the “[Redacted] Report”. The price shall
come from the [Redacted] line item reported in cents/pound for November , 2004 . PTA is
quoted as “Delivered” so no freight adjustment shall be made. For the term of this Agreement, or
any extension thereof, the stoichiometric material conversion (“conversion”) used to calculate
Seller’s raw material cost for PTA shall be [Redacted];

     (ii) The
cost of MEG - In determining said base price as of November 1, 2004, the
cost of MEG for the month beginning November 1, 2004, and for each month thereafter during the
term of this Agreement, or any extension thereof, shall be the published market price, as quoted
in the [Redacted]. The price shall come from the [Redacted] line item reported in
cents/pound for November, 2004. MEG is quoted FOB so freight shall be added as provided
in section 3(a) {iii). If a range is reported, the lower of the prices quoted shall be used. Any
retroactive adjustments indicated will be reflected in debits or credits for the affected period
as indicated. For the term of this Agreement, or any extension thereof, the stoichiometric
material conversion (“conversion”) used to calculate Seller’s raw material cost for MEG will be
[Redacted];

     If the listed [Redacted] MEG (FOB) price is [Redacted] will be reduced equivalently. The
[Redacted] MEG base price will be adjusted by the [Redacted]. One MEG is equal to [Redacted]. A
Exhibit “C-1”, entitled MEG Base Price, illustrates several examples.

     (iii) MEG
Freight Cost From Point Comfort, TX. - Seller shall be reimbursed by
Buyer for actual cost for freight from Point Comfort, Texas, to Lake City, South Carolina. As of
the effective date of this Agreement, the said freight cost is [Redacted] per pound
([Redacted]/pound). In addition to said freight cost, [Redacted]. Seller and Buyer are to review
the rates annually and upon evidence of change of the actual rate (based on a per pound amount)
this amount will be adjusted accordingly.

     (b) Material
Price Modifications - The base price, as set forth in Section 3(a) above,
shall be adjusted for changes in FOB market price for MEG and DELIVERED market price for PTA
(increased or decreased) as of the first day of each month thereafter. For Chip delivered to the
Buyer during months where the current month’s PTA or MEG prices have not been finalized, as
provided in section 3(a), the base price invoiced to the Buyer shall be the market price for the
previous month. The price modifications as set forth above are illustrated on Exhibit “B”,
entitled Chip Pricing Terms, attached hereto.

     A new Exhibit “B-1”, entitled Chip Pricing Terms, setting forth the bulk purchase price of
Chip per pound, effective as of November 1, 2004, FOB Lake City and updating the market price of
PTA and MEG, set forth under Price Modifications on Exhibit “B”, shall be signed by both parties
and attached to this Agreement.

     (b2)Rebates- At the beginning of the following month a rebate of [Redacted] per pound
([Redacted]/ pound) for net shipments in the previous month will be issued to the Buyer for each
pound of Chip purchased from Seller during that month.

3

 

     (c) Annual Adjustments to Base Price –If this Agreement is extended as provided for in
Section 9, beginning on November 1, 2007 and annually thereafter (if extended), annual adjustments
to the base price, as provided in section 3(a) , shall be made, allowing for increases or decreases
in Seller’s cost of Labor and Energy.

     In determining said annual adjustments to the base price:

     (i) Labor Cost Adjustment: On or before June 30, 2004, the average hourly gross
earnings per production worker in [Redacted], as reported in the [Redacted], shall be presented to
Buyer by Seller. This shall be the baseline upon which annual adjustments will be made. Beginning
on June 30, 2005 , and continuing at the end of each year of the contract period, for each
1% change from the baseline established on June 30, 2004, presented above, the price paid by Buyer
shall adjust by [Redacted] cents per pound ([Redacted]/pound).

     (ii) Energy Cost Adjustment: On or before June 30, 2004, the price of No.2 oil, as
presented in [Redacted], shall be presented to the Buyer by the Seller. This shall be the baseline
upon which annual adjustments will be made. Beginning on June 30 , 2005, and continuing at
the end of each extension year, for any increase or decrease from the per gallon baseline
established on June 30, 2004, the price paid by the Buyer shall adjust by [Redacted] cents
([Redacted]) times the total amount of the change from the baseline.

SECTION 4. PAYMENT OF PURCHASE PRICE - Seller shall render its invoice to Buyer as
follows:

     (a) Daily, using the base bulk price as in effect for the Chip delivered to Buyer that day;

     (b) Monthly, for the increase in the total purchase price of Chip over the base bulk price of
raw materials, or for crediting Buyer for the decrease in the raw material price, as provided in
section 3 hereof, shipped to Buyer during the month and reflecting the adjustments to the base bulk
price.

     (c) Payment of the purchase price for (a) above shall be net thirty (30) days from shipping
date (B/L date) and for the adjustments in (b) shall be net thirty (30) days from receipt of the
invoice by Buyer and shall be made to Seller. Interest at prime rate (hereinafter defined), as
reported in the Wall street Journal, per month will accrue and become immediately due on all
balances not paid in full within thirty (30) days from the date Buyer receives invoice from
Seller. (The prime rate being the base rate on corporate loans posted by at least seventy-five
percent (75%) of the nations thirty (30) largest banks.)

SECTION 5.
DELIVERY - Delivery shall be made FOB Seller’s plant, Lake City.
Identification of the goods shall occur when they are placed in the hands of the carrier
designated by Buyer. Buyer shall bear all risk of loss from the time the goods are placed in the

4

 

hands of the carrier.

SECTION 6.
INDEMNIFICATION - Buyer agrees to defend and indemnify Seller for all claims,
lawsuits, and liabilities of any type in connection with or resulting from any personal injuries
sustained by any persons in connection with or resulting from the delivery and/or handling of the
Chip after the Chip has been placed in the hands of the carrier designated by Buyer, regardless of
whether Seller’s negligence is alleged to have caused or
contributed to such personal injuries.

SECTION 7.
EXEMPLARY/PUNITIVE WAIVER - Both parties hereby unconditionally agree that
neither party shall ever be liable to the other party for any consequential, special, or
exemplary/punitive damages of any type in connection with or resulting from this Agreement or the
breach thereof, under any circumstances.

SECTION 8. SHORTAGE OF
CHIP - In the event Seller, because of events beyond its control at
its Lake City plant other than Force Majeur situations as defined in section 10, for which
performance is excused, has a shortage of Chip and is unable to meet deliveries as ordered, Seller
will obtain, at no cost to Buyer, from its other plants or other sources additional Chip of
similar quality in order to meet orders.

     Seller understands that Buyer cannot operate its spinning plant in Yadkinville, North Carolina
without the delivery of Chip contracted for under this Agreement, and agrees that if, for any
reason other than Force Majeur situations, as defined in Section 10, for which performance is
excused, it is unable to deliver to Buyer the amount of Chip ordered, Buyer may purchase the
difference in the amount of Chip ordered and amount Seller was able to deliver (shortage) from
other sources and Seller will reimburse Buyer for the cost of the Chip necessary to make up the
shortage, in excess of the base price Buyer was paying Seller for Chip at the time the shortage
occurred.

SECTION 9. EXTENDED
TERM - The parties agree that they will, upon thirty (30) days written
notice by one of the parties to the other, meet at a mutually agreeable time and place during the
month of March, 2006, and on similar notice from one of the parties, meet during the month of
March of each year thereafter for as long as this Agreement is in effect and negotiate in good
faith to extend the term of this Agreement for an additional one year term. Any such extension of
the term of this Agreement will be evidenced by a writing signed by authorized representatives of
the parties.

SECTION 10. FORCE
MAJEUR - Buyer and Seller shall not be deemed to have defaulted or
failed to perform hereunder if their inability to perform or default shall have been caused by an
event or events beyond the control and without the fault of Buyer or Seller, including without

5

 

limitations, acts of government, fire, flood, explosions, acts of nature, strikes, labor disputes,
vandalism, or civil riots.

SECTION 11.
INTERRUPTION IN PERFORMANCE - Whenever an event specified in Section 10 above
occurs, notice of such event shall immediately be given to the other party.

SECTION 12.
TERMINATION - In the event Seller or Buyer institutes or shall have instituted
against it proceedings in bankruptcy for liquidation, reorganization or readjustment of any of its
respective debts under the Bankruptcy Act, as amended, or any part thereof, or under any other act
or law, whether state or federal, for the relief of debtors now or hereafter existing, and the
same shall not have been discharged within thirty (30) days after commencement, or shall make an
assignment for the benefit of its creditors, the party that is not the subject of said proceeding
shall have the right to immediately terminate this Agreement upon giving notice to the other
party.

SECTION 13. WARRANTY
AGAINST INFRINGEMENTS - Except for instances of Modified Polymers
requested by Buyer and addressed below in “Section 14. Modified Polymers”, Seller warrants that the
Chip being sold to Buyer under this Agreement shall not infringe upon any United States or foreign
patent and Seller shall indemnify Buyer against all judgments, decrees, costs, and expenses
resulting from any alleged infringement and except for instances of Modified Polymers requested by
Buyer and addressed below in “Section 14. Modified Polymers”, shall defend, upon written request of
Buyer, at its own cost any action which may be brought against Buyer under any claim of patent
infringement in relation to said Chip.

SECTION 14. MODIFIED POLYMERS - Seller shall keep Buyer informed of any additional
additives added to PET Chip to meet changing market requirements. Buyer, at its additional cost,
can request additional ingredients not already included in Seller’s standard PET Chip be added in
order to meet its market requirements but for any claims, lawsuits, or liabilities of any type
related to or resulting directly or indirectly from such specifications for Modified Polymers
requested by Buyer, Buyer shall at its own cost defend and indemnify Seller against all judgments,
decrees, costs, and expenses, including but not limited to claims or lawsuits alleging patent
infringement or theft or misuse of trade secrets of any type.

SECTION 15. MERGER OR
CONSOLIDATION - In the event of merger, share exchange, or other
transfer of ownership of either party, this Agreement shall remain in full force and effect.

6

 

SECTION 16.
NOTICES - All notices and other communications hereunder shall be in writing
and shall be deemed to have been duly given if delivered or mailed, registered, return receipt
requested, postage prepaid, as follows:

	 	 	 	 	 
	 	 	(a) If to Nan Ya Plastics Corp., America:
	 
	 	 	 	 
	 	 	Nan Ya Plastics Corp., America
	 	 	P.O. Box 939
	 	 	Beulah Road, Hwy. 52 South
	 	 	Lake City, SC 29560
	 	 	ATTENTION: Sales Department
	 
	 	 	 	 
	 	 	(b) If to Unifi Manufacturing, Inc.:
	 
	 	 	 	 
	 	 	Unifi Manufacturing, Inc.
	 	 	P.0. Box 19109
	 	 	Greensboro, NC 27419-9109
	

	 	ATTENTION:
	 	General Counsel
	

	 	 	 	(presently Charles F. McCoy)

SECTION 17.
MODIFICATION - No modification, amendment, extension, renewal, recession,
termination, or waiver of any of the provisions contained herein, or any future representations,
promises or conditions in connection with this Agreement shall be binding upon either party
unless in writing and signed by an officer on its behalf.

SECTION 18.
ARBITRATION - Any dispute, controversy or claim for damages or otherwise,
arising under or in relation to this Agreement, or any modification thereof, shall be settled by
arbitration. Such arbitration shall be held in the City of New York before a panel of three (3)
arbitrators, with each party appointing one arbitrator and the two parties appointing a third
(unless the parties hereto agree to one (1) arbitrator) under the Rules of the General Arbitration
Counsel of the Textile and Apparel Industry. Both parties shall be bound by the arbitrators’
decision and judgment upon such decision may be entered in any state or Federal Court of competent
jurisdiction. The parties hereto consent to the jurisdiction of the Supreme Court of the State of
New York or the United States District Court for the Southern District of New York and further,
any process or notice of motion or any application to a court or a judge thereof, may be sent
within or without the State of New York by certified or registered mail, or by personal service,
provided a reasonable time for appearance is allowed.

SECTION 19.
ASSIGNMENT - This Agreement may not be assigned by either party without the
prior written consent of the other party, provided however, Buyer may assign this Agreement

7

 

to any of its subsidiaries
(“Assignee”), effective as of the date Notice of such assignment is
given to Seller. In the event Buyer assigns this Agreement and the said Assignee fails to perform
or satisfy any of the Buyer’s obligations under the terms and conditions of this Agreement, Buyer
will promptly and fully do so in said Assignee’s place. Buyer shall pay and reimburse the Seller
for all damages, costs, expenses and losses arising or resulting from Assignee’s failure to perform
or satisfy the Buyer’s obligations under this Agreement.

     Buyer’s liability is direct and continuing. Seller shall not be required to pursue any
remedies against Assignee as a condition to enforcement of Buyer’s guaranty of the Assignee’s
compliance and performance of this Agreement.

SECTION 20. GOVERNING LAW - This Agreement shall be governed by and construed and
interpreted in accordance with the laws of the State of New York.

SECTION 21. CONFIDENTIALITY –

     The Parties acknowledge that throughout the term of this Agreement that certain Confidential
Information may be disclosed by one party to the other. If and when such Confidential Information
is disclosed:

	 	(a)  	The Parties shall disclose Confidential Information only to such employees,
representatives or agents who are under obligation of secrecy and are directly
involved in the matter.
	 
	 	(b)  	Neither Party shall directly or indirectly exploit on a commercial basis
Confidential Information received from the other Party and shall make no use of such
Confidential Information otherwise than within the perimeters of this Agreement unless
agreed to in writing by the other.
	 
	 	(c)  	“Confidential Information” includes any information related to the business of
either Party acquired by the other regardless of the manner of acquisition, whether
through communications, visits, presentations, or the like, or any sensory
perceptions, or whether such information has been given verbally or in writing, i.e.
in the for, of date, notes, drawing, documentation, software, reports or analysis, or
in the form of objects such as samples or models and the terms and conditions of this
Agreement and the transactions contemplated herein.
	 
	 	(d)  	Confidential Information does not include such information which can be
proved:

	 	(i)  	to have been part of the public domain at the time of
disclosure to the receiving Party;
	 
	 	(ii)  	to have been known to the receiving Party at the time of
disclosure by the other Party;

8

 

	 	(iii)  	to have become part of the public domain after having been
disclosed to the receiving Party and other than by default of the receiving
Party or its employees;
	 
	 	(iv)  	to have come to the knowledge of the receiving Party after
disclosure by the other Party and not acquired by the receiving Party from
sources not entitled to dispose of such Confidential Information or being
under an obligation of secrecy to the other Party;
	 
	 	(v)  	available by the inspection of products or services marketed
or offered for sale in the ordinary course of business by either Party hereto
or others.

	 	(e)  	Nothing in this document shall or may be construed as granting any rights
express or implied to Confidential Information furnished by one Party to the other.

     IN WITNESS WHEREOF, the parties have executed this Agreement by their duly authorized
officers or representatives the day and year written above.

	 	 	 	 	 	 	 	 	 
	NAN YA PLASTICS CORP., AMERICA	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	By:

	 	/s/ T. Son
	 	 	 	March 8, 2005	 	 
	Title:

	 	Assistant Vice President
	 	 	 	Date:	 	 
	 
	 	 	 	 	 	 	 	 
	UNIFI MANUFACTURING, INC.	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	By:

	 	/s/ Tom Caudle
	 	 	 	March 18, 2005	 	 
	Title:

	 	V.P., Global Operations
	 	 	 	Date:	 	 

9

 

EXHIBIT A

	 	 	 
	Spec.:

	 	Semi Dull Chip (N401)
	 
	 	 
	Description:

	 	General Grade Specifications

	 	 	 	 	 	 	 	 	 
	Property	 	Unit	 	A-Grade	 	Method
	 
	 	 	 	 	 	 	 	 
	A. IV (Intrinsic viscosity)

	 	 	dL/g
	 	0.645 ±.010
	 	25°C Bath, Solvent 60% Phenol
& 40% TCE
	 
	 	 	 	 	 	 	 	 
	B. Ash Content

	 	 	%	 	 	0.35 ± 0.07	 	 
	 
	 	 	 	 	 	 	 	 
	C. Color
	 	 	 	 	 	 	 	 
	          1. L, Luminance

	 	 	-	 	 	77.5 ± 2.0	 	 
	          2. b, Yellowness

	 	 	-	 	 	0.0 ± 2.0	 	 
	 
	 	 	 	 	 	 	 	 
	D. DEG

	 	 	mole %
	 	2.50 ± 0.30	 	 
	 
	 	 	 	 	 	 	 	 
	E. Moisture Content

	 	 	%	 	 	< 0.30	 	 
	 
	 	 	 	 	 	 	 	 
	F. Shape/Dimension

	 	 	 	 	 	Cylindrical/3mm longx3mm diameter	 	 
	 
	 	 	 	 	 	 	 	 
	G. Melting Point

	 	 	°C	 	257 ± 3	 	 
	 
	 	 	 	 	 	 	 	 
	H. COOH

	 	 	equ/gxl0-6
	 	32 ± 10	 	 
	 
	 	 	 	 	 	 	 	 
	I. Thermal Stability

	 	 	Pass/Fail
	 	 	 	 

Page 1 of 2

10

 

	 	 	 
	Spec.:

	 	Full Bright Chip (A218)
	 
	 	 
	Description:

	 	General Grade Specifications

	 	 	 	 	 	 	 	 	 
	Property	 	Unit	 	A-Grade	 	Method
	 
	 	 	 	 	 	 	 	 
	A. IV (Intrinsic Viscosity)

	 	 	dL/g
	 	0.670 ± 0. 010
	 	25°C Bath, Solvent 60% Phenol & 40% TCE
	 
	 	 	 	 	 	 	 	 
	B. Ash Content

	 	 	%	 	 	0.035 ± 0.005	 	 
	 
	 	 	 	 	 	 	 	 
	C. Color
	 	 	 	 	 	 	 	 
	1. L, Luminance

	 	 	-	 	 	74 ± 2.0	 	 
	2. b, Yellowness

	 	 	-	 	 	0.0 ± 2.0	 	 
	 
	 	 	 	 	 	 	 	 
	D. DEG

	 	 	mole %
	 	2.70 ± 0.30	 	 
	 
	 	 	 	 	 	 	 	 
	E. Moisture Content

	 	 	%	 	 	< 0.30	 	 
	 
	 	 	 	 	 	 	 	 
	F. Shape/Dimension

	 	 	 	 	 	Cylindrical/3mm longx3mm diameter	 	 
	 
	 	 	 	 	 	 	 	 
	G. Melting Point

	 	 	°C	 	 	250 ± 3	 	 
	 
	 	 	 	 	 	 	 	 
	H. COOH

	 	 	equ/gxl0-6
	 	35 ± 10	 	 
	 
	 	 	 	 	 	 	 	 
	I. Thermal Stability

	 	 	Pass/Fail
	 	 	 	 

Page 2 of 2

11

 

EXHIBIT B

Chip Pricing Terms

[Redacted]

12

 

EXHIBIT C

MEG Base Price

[Redacted]

13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00081-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00081-of-00352.parquet"}]]